Adagene Inc. (ADAG)
Nasdaq: ADAG · Pharmaceutical Preparations · Jiangsu, CN · filing with the SEC since 2020
Who owns Adagene Inc.
As filed with the SECHolders of 5% or more
5
HAN 2020 Irrevocable Trust holds 11.2% of Ordinary shares, par value USD $0.0001 per share, as its SCHEDULE 13D/A filed Jun 8, 2026 says.
Directors and officers
10
report now, of 10 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
HAN 2020 Irrevocable Trust
SCHEDULE 13D/A · filed Jun 8, 2026 · Ordinary shares, par value USD $0.0001 per share · 15.6% in Feb 19, 2025
Janus Henderson Group PLC
SCHEDULE 13G · filed May 7, 2026 · American Depository Receipt
Smith Vincent C
SCHEDULE 13G/A · filed Jan 29, 2026 · Ordinary Shares · 6.9% in Feb 4, 2025
OT Management, LLC
SCHEDULE 13G/A · filed Feb 3, 2025 · ordinary shares · 5.9% in Sep 24, 2024
Chernett Jorey
SCHEDULE 13G · filed Mar 18, 2026 · Ordinary shares, par value US$0.0001 per share
Panacea Venture Healthcare Fund II, L.P.
SCHEDULE 13G/A · filed Nov 14, 2025 · Ordinary Shares · reported falling below 5%, from 5.5% in Feb 14, 2025
WuXi PharmaTech Healthcare Fund I L.P.
SCHEDULE 13G/A · filed Aug 14, 2026 · Ordinary shares, par value US$0.0001 per share · reported falling below 5%, from 5.9% in May 15, 2026
FIL Limited
SCHEDULE 13G/A · filed May 12, 2025 · COMMON STOCK · reported falling below 5%, from 7.8% in Feb 12, 2025
Fmr LLC
SCHEDULE 13G/A · filed Jul 2, 2025 · COMMON STOCK · reported falling below 5%
General Atlantic Singapore Fund Pte. Ltd.
SCHEDULE 13G/A · filed Feb 17, 2026 · Ordinary shares, par value US$0.0001 per share · reported falling below 5%
What ADAG reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Adagene (Hong Kong) Limited
An entity · legal entity · owns, named in the 20-F filed Apr 1, 2026
Adagene Australia PTY Ltd.
An entity · legal entity · owns, named in the 20-F filed Apr 1, 2026
8 subsidiaries in 6 countries, from the list filed with the 20-F filed Mar 29, 2024.
Insider tradesForm 4
0sales
5purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$200,000bought, in dollars
Open-market trades on Form 4 from Oct 2, 2025 to Oct 2, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 2, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 10 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Luo Peter | Chief Executive Officer | 0 | $0 | 0 | 3 | $100,000 |
| Tam Man Kin | Chief Financial Officer | 0 | $0 | 0 | 1 | $0 |
| Do Cuong V | director | 0 | $0 | 0 | 1 | $0 |